NewLeaf Symbiotics nabs $24 mln Series C
St. Louis, Missouri-based NewLeaf Symbiotics, an agricultural biotech company, has secured $24 million in Series C financing. Monsanto Growth Ventures and Otter Capital led the round with participation from other backers that included Lewis & Clark Ventures, Rockport Capital, Pangaea Ventures and Open Prairie Ventures.
10 July 2017•1 min read
